(Q44402756)

2 December 2017

Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients (English)

1 reference

2 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

24 December 2023

author name string

Fabien Metivier

4

1 reference

2 December 2017

Hassan Adda

5

1 reference

2 December 2017

Bruno Pannier

6

1 reference

2 December 2017

Gérard M. London

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694318

24 December 2023

Sylvain J. Marchais

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694318

24 December 2023

Alain P. Guerin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694318

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694318

24 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

http://www.kidney-international.org/article/S0085253815492257/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694318

https://api.elsevier.com/content/article/PII:S0085253815492257?httpAccept=text/xml

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

https://api.elsevier.com/content/article/PII:S0085253815492257?httpAccept=text/plain

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Kidney International. Supplement

24 December 2023

published in

1 reference

2 December 2017

84

1 reference

2 December 2017

S88-93

1 reference

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

2 December 2017

2

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Impact of left ventricular hypertrophy on survival in end-stage renal disease

24 December 2023

3

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Impact of aortic stiffness on survival in end-stage renal disease

24 December 2023

4

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

24 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

24 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

24 December 2023

9

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Salt and water retention and calcium blockade in uremia

24 December 2023

10

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

24 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Cardiac and arterial interactions in end-stage renal disease.

24 December 2023

13

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis

24 December 2023

15

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis

24 December 2023

16

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

24 December 2023

17

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis.

24 December 2023

18

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

C-reactive protein as an outcome predictor for maintenance hemodialysis patients.

24 December 2023

19

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

24 December 2023

20

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

24 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans

24 December 2023

23

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients

24 December 2023

24

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Vascular inflammation and the renin-angiotensin system

24 December 2023

26

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo

24 December 2023

27

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II.

24 December 2023

28

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells

24 December 2023

29

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo

24 December 2023

30

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?

24 December 2023

31

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells

24 December 2023

32

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

24 December 2023

33

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.63.S84.25.X

24 December 2023

Identifiers

0 references

1 reference